J2KBIO Co., Ltd.

KOSDAQ:A420570 Stock Report

Market Cap: ₩48.7b

J2KBIO Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jaeseop Lee

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership27.8%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Analysis Article • Dec 17

J2KBIO Co., Ltd.'s (KOSDAQ:420570) Prospects Need A Boost To Lift Shares

J2KBIO Co., Ltd.'s ( KOSDAQ:420570 ) price-to-sales (or "P/S") ratio of 1.8x might make it look like a strong buy right...
Analysis Article • Feb 27

A Piece Of The Puzzle Missing From J2KBIO Co., Ltd.'s (KOSDAQ:420570) 28% Share Price Climb

J2KBIO Co., Ltd. ( KOSDAQ:420570 ) shareholders have had their patience rewarded with a 28% share price jump in the...
Analysis Article • Feb 27

J2KBIO Co., Ltd.'s (KOSDAQ:420570) Shares Leap 28% Yet They're Still Not Telling The Full Story

The J2KBIO Co., Ltd. ( KOSDAQ:420570 ) share price has done very well over the last month, posting an excellent gain of...
Analysis Article • Aug 23

J2KBIO (KOSDAQ:420570) Has A Rock Solid Balance Sheet

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

CEO

Jaeseop Lee

no data
Tenure

Jaeseop Lee is Chief Executive Officer of J2KBIO Co. Ltd.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/16 15:26
End of Day Share Price 2026/07/16 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

J2KBIO Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.